Related Experiment Video
Updated: May 5, 2026

08:30
Visualization of Recombinant DNA and Protein Complexes Using Atomic Force Microscopy
Published on: July 18, 2011
22.7K
Mechanical Properties Measured by Atomic Force Microscopy Help Evaluate Different Constructions of Re-engineered
Leqian Zhao1, Xuejiao Chen2, Junjie Shen3
1Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
ACS Nano
|September 5, 2025
Summary
Chimeric antigen receptor-T (CAR-T) cell therapy shows promise, but optimizing its efficacy, especially in solid tumors, remains key. This study reveals that lower CAR-T cell binding forces enhance therapeutic effectiveness by improving cell detachment and killing efficiency.
Area of Science:
- Immunology
- Biophysics
- Cancer Biology
Background:
- Chimeric antigen receptor-T (CAR-T) cell therapy has revolutionized hematological cancer treatment but faces challenges in solid tumors, including toxicity and limited persistence.
- The role of cellular mechanics and biophysical properties in CAR-T cell function is largely unexplored, representing a critical knowledge gap.
Purpose of the Study:
- To investigate the impact of different CAR designs, including single- and dual-target CARs, on CAR-T cell efficacy against CD19 and/or CD123 expressing cancers.
- To explore the relationship between CAR-T cell biophysical properties, specifically binding forces, and their therapeutic outcomes in vitro and in vivo.
- To elucidate the role of cellular mechanics in CAR-T cell function and identify design principles for improved CAR-T therapies.
Main Methods:
- Development and testing of various CAR molecules targeting CD19 and/or CD123.
- In vitro assessment of CAR-T cell cytotoxicity against relevant cancer cell lines.
- In vivo evaluation of CAR-T cell efficacy in preclinical mouse models.
- Utilizing atomic force microscopy (AFM) to quantify the binding forces between CAR-T cells and target antigens.
Main Results:
- Single-specific CAR-T cells targeting CD19 or CD123 demonstrated potent in vitro cytotoxicity.
- Dual-target CAR-T cells, particularly those arranged in parallel or series configurations, exhibited optimal in vivo efficacy.
- A negative correlation was observed between CAR-T cell-antigen binding forces and therapeutic efficacy in vivo, suggesting lower binding forces enhance killing efficiency.
- Lower binding forces were associated with faster CAR-T cell action and detachment, leading to improved tumor cell killing.
Conclusions:
- Cellular mechanics, specifically binding forces, are critical determinants of CAR-T cell therapy efficacy.
- Optimizing CAR-T cell binding forces through rational design can enhance therapeutic outcomes, potentially overcoming limitations in solid tumors.
- This study provides novel insights into the biophysical underpinnings of CAR-T cell function, guiding future development of more effective CAR-T therapies.

